CE Mark for IOL and delivery system

Article

Abbott Medical Optics (AMO) has announced the launch and CE Mark of approval for both the Tecnis multifocal toric IOL and iTec preloaded delivery system at the ESCRS in Milan this year.

Abbott Medical Optics (AMO) has announced the launch and CE Mark of approval for both the Tecnis multifocal toric IOL and iTec preloaded delivery system at the ESCRS in Milan this year.

The IOL is a premium lens solution for astigmatic cataract patients and provides spectacle-independence for the patient. It can also correct presbyopia and corneal astigmatism.

AMO also introduced the iTec preloaded delivery system, which allows the safe implantation of the IOL without having to manually load the lens. The delivery system is a highly-controlled, screw-style device providing reliability and efficiency for the surgeon.

Jim Mazzo, senior vice president of AMO, stated, "Cataract surgeons in Europe now have two new products available to address the unique lifestyle needs of their patients, By receiving CE Mark for the TECNIS Multifocal Toric IOL and the TECNIS iTec Preloaded Delivery System, Abbott continues to demonstrate its commitment to advancing cataract vision care innovation and providing high quality patient outcomes."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.